Gyre Therapeutics, Inc. Property, Plant and Equipment
Gyre Therapeutics, Inc. (GYRE) had Property, Plant and Equipment of $27.28 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-07
- 2026-06-30: Property, Plant and Equipment, Net $27.28M.
- 2026-03-31: Property, Plant and Equipment, Net $23.57M.
- 2025-12-31: Property, Plant and Equipment, Net $27.55M; Property, Plant and Equipment, Net as first filed $23.60M.
- 2025-09-30: Property, Plant and Equipment, Net $23.61M.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2026-06-30 | $27.28M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $23.57M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $27.55M 10-Q · filed 2026-08-07 | $23.60M 10-K · filed 2026-03-13 |
| 2025-09-30 | $23.61M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $23.40M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $23.52M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $23.88M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $24.44M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $23.67M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $23.56M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $23.29M 10-K · filed 2025-03-17 | |
| 2023-03-31 | $1.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $17.71M 10-K · filed 2024-03-27 | $4.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $124.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $164.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $857.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $970.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $1.09M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $684.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $382.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $433.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $439.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $481.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $296.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $304.00K 10-K · filed 2021-03-04 | |
| 2019-09-30 | $339.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $371.00K 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $356.00K 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $386.00K 10-K · filed 2020-02-20 | |
| 2018-09-30 | $255.00K 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $291.00K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $325.00K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $276.00K 10-K · filed 2019-03-08 | |
| 2017-09-30 | $315.00K 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $358.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $399.00K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $444.00K 10-K · filed 2018-03-19 | |
| 2016-09-30 | $716.00K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $803.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $682.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $698.00K 10-K · filed 2017-03-08 | |
| 2015-09-30 | $709.00K 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $653.00K 8-K/A · filed 2015-10-23 | $149.00K 10-Q · filed 2015-07-31 |
| 2015-03-31 | $373.00K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $911.00K 10-K · filed 2016-03-09 | $428.00K 10-K · filed 2015-03-16 |
| 2014-09-30 | $483.00K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $541.00K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $611.00K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $1.77M 8-K/A · filed 2015-10-23 | $682.00K 10-K · filed 2014-03-14 |
| 2013-09-30 | $748.00K 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $944.00K 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $1.50M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $1.64M 10-K · filed 2014-03-14 | |
| 2011-12-31 | $5.04M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |